The FDA has approved a new drug called zolbetuximab designed to attack a novel target that’s in a type of stomach cancer.

Noah S. Kalman, MD, MBA, discusses the most common types of thyroid cancer and their respective prognosis.

Initial OnKure Therapeutics, Inc. data from PIKture-01 study on OKI-219 for PI3Ka-H1047R breast cancer expected in Q4, 2024.

Experts stressed that raising awareness about cancer is essential for fully leveraging medical advancements. Despite ...

Portrush-founded 6D-Dementia Ltd and Belfast’s Klas Therapeutics named Northern Ireland regional winners in InterTradeIreland ...

Cancer immunotherapy was once hailed as a breakthrough in defeating cancer. Explore its evolution, early success, and current ...

Radiation therapy is a common component of breast cancer treatment for patients. The high-powered beams of intense energy ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

In 1893, the American Journal of the Medical Sciences reported on ten patients whose large and hitherto incurable cancers had ...

Researchers conducted a post hoc analysis to evaluate incidence, severity, and time to first onset of rash and paronychia in patients with lung cancer treated with amivantamab. Rash, paronychia, and ...

Dermatofibrosarcoma protuberans (DFSP) is a rare skin sarcoma known for its high recurrence rates, making treatment ...

Before King Charles concluded his royal tour in Australia, the monarch visited a cancer centre in Sydney to learn more about ...